Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

OnlyRx vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.4

OnlyRx

Best for Buyers comparing cash-pay compounded-GLP-1 platforms who want oral-tablet form factors (ODT) alongside the standard subcutaneous injection, value the transparency of named prescribers + named pharmacy partners, and accept a four-pharmacy fulfillment model rather than a single named compounder.
★★★☆☆3.2

Starting at $179/mo

Compounded Semaglutide (injection + ODT)Compounded Tirzepatide (injection + ODT)Branded Ozempic/Wegovy/Zepbound/Mounjaro Available4 Named Physicians (MD/DO)
Visit OnlyRx
8.7

Vytora Health

Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
★★★★4.4

Starting at $150/mo

CompoundedBrand-Name Available (Mounjaro + Zepbound)All 50 States + DCLegitScript Approved
Visit Vytora Health

Side-by-Side Comparison

FeatureOnlyRxVytora Health
Overall Score6.4/108.7/10
Starting Price$179/mo$150/mo
Editorial Rating3.2 ★ /54.4 ★ /5
Features10 features10 features
States Available051
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

OnlyRx

Pros

  • Four-pharmacy fulfillment network (Belmar, Strive, Epiq Scripts, Casa Pharma RX) — three of four are already in our pharmacy registry with independent verification
  • Named prescriber roster on the public site (Dr. Carr MD, Dr. Tenbrink MD, Dr. Italia MD, Dr. Mansour DO) — stronger transparency than peers with anonymous clinical networks
  • ODT (oral disintegrating tablet) compounded form for both semaglutide and tirzepatide — uncommon offering that fits needle-averse patients
  • Server-side rendered Nuxt site (not a SPA blank shell) — pricing, drug list, pharmacy partners, and physician roster all extractable from the static HTML, reducing the YMYL opacity penalty most newer entrants take
  • LegitScript Certified claim on the public site
  • Branded Ozempic/Wegovy/Zepbound/Mounjaro available alongside the compounded line — patients can step up to FDA-approved branded products without switching platforms

Cons

  • Promo pricing ($179 semaglutide injection floor) is marketed prominently; the post-promo maintenance dose pricing is not surfaced on the static site
  • No specific titration ladder pricing — buyers can't see what they'll pay at 1.0 mg or 2.4 mg semaglutide maintenance
  • Refund / cancellation policy not stated on the homepage
  • Lab-work requirement not stated — most legitimate GLP-1 telehealth platforms require baseline labs or a recent metabolic panel
  • LegitScript merchant-ID independent lookup at safe.legitscript.com NOT verified this cycle (claim is on the site but independent confirmation pending)
  • Operating corporate entity not disclosed in the static HTML — the platform self-describes as connecting patients to independent licensed providers but does not name the operating LLC or corporation
  • Epiq Scripts is the one named pharmacy partner not yet independently verified in our pharmacy registry

Vytora Health

Pros

  • All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
  • Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
  • LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
  • Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
  • Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
  • Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
  • Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens

Cons

  • Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
  • Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
  • Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
  • Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
  • Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)

Our Verdict

Winner: Vytora HealthScore: 8.7/10

Vytora Health edges out OnlyRx with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. OnlyRx remains a solid alternative, especially if you're looking for Buyers comparing cash-pay compounded-GLP-1 platforms who want oral-tablet form factors (ODT) alongside the standard subcutaneous injection, value the transparency of named prescribers + named pharmacy partners, and accept a four-pharmacy fulfillment model rather than a single named compounder..

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring OnlyRx and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.